Our Research Advisory team
-
Dr. Hans Vink
Dr. Vink, Co-Founder, Director of Advanced Research, is a glycocalyx research pioneer, the world’s leading glycocalyx researcher, and the inventor of the GlycoCheck™ testing device. He has published over 250 scholarly papers on the glycocalyx, and his research has been cited in more than 16,000 citations.
-
Robert Long
Robert Long, Co-Founder, Director of Nutraceutical Research, is a research collaborator with Dr. Vink and the developer of the glycocalyx-regenerating nutraceuticals, the latest refinement being ReVasca™. He formulated the glycocalyx nutraceuticals, and Dr. Vink validated their efficacy with GlycoCheck™.
About the Institute
The Glycocalyx Research Institute, founded in 2012 and led by Dr. Hans Vink and Robert Long, aims to provide education and training on the endothelium glycocalyx and the microvascular system, as well as consult and design glycocalyx and microvascular-based research studies.
The Institute creates and delivers medical devices and nutritional supplements that monitor and support the health and well-being of the endothelial glycocalyx and the microvascular system.
The company’s flagship product is GlycoCheck™, a clinically validated, class-one medical device that enables monitoring and evaluation of the overall strength and dimension of the glycocalyx and arterial health.
ReVasca
ReVasca™ is the only supplement approved and clinically validated by Dr. Vink at the Glycocalyx Research Institute that supports and repair the glycocalyx and the microvascular system. It represents the advancement in nitric oxide focused supplements, succeeding the original formulations known as Arterosil and Endocalyx Pro.*
By repairing and maintaining the health of the glycocalyx, ReVasca™ helps ensure efficient microcirculation. This, in turn, aids in the optimal delivery of nutrients and oxygen to cells, proper removal of waste products, and overall vascular health, potentially reducing the risk of various microvascular-related conditions.
GlycoCheck™
With the revolutionary patented imaging software and hardware system developed by Dr. Hans Vink, healthcare professionals can identify and monitor the contribution of microvascular dysfunction and glycocalyx damage during disease development.
The Glycocalyx Research Institute has also developed a game-changing, proprietary, anti-aging supplement, ReVasca™, which delivers the anti-aging building blocks essential to maintaining a healthy endothelial glycocalyx and capillaries in the microvascular system.
This unique combination of GlycoCheck™ and the ReVasca™ nutraceutical has proven to be successful in restoring, regenerating, and protecting the glycocalyx gel lining of the microvascular system in order to prevent organ starvation.